Skip to main content
. Author manuscript; available in PMC: 2018 Mar 6.
Published in final edited form as: Eur J Clin Nutr. 2017 Sep 6;72(1):130–135. doi: 10.1038/ejcn.2017.138

Table 4.

Infant mean hemoglobin concentrations (g/dL) by treatment arma

Placebo Zinc Multivitamins Multivitamins plus Zinc

Baseline 508 10.7 (10.6, 10.9) 497 10.6 (10.5, 10.7) 507 10.7 (10.6, 10.8) 494 10.6 (10.5, 10.8)
6 mo 347 10.0 (9.9, 10.1) 350 10.0 (9.8, 10.1) 354 10.0 (9.9, 10.1) 352 10.0 (9.9, 10.1)
12 mo 272 9.7 (9.5, 9.8)b 273 9.6 (9.5, 9.7)c 271 9.9 (9.7, 10.0)b,c 266 9.7 (9.6, 9.9)
18 mo 168 9.6 (9.4, 9.8)d 159 9.6 (9.4, 9.7)c 165 9.9 (9.7, 10.1)c,d 167 9.9 (9.4, 10.0)
a

Values are Ns followed by mean haemoglobin (g/dL) with 95%CI from ANOVA models.

b

ANOVA post-hoc comparison with Bonferroni correction between multivitamin and placebo treatment P ≤ 0.10.

c

ANOVA post-hoc comparison with Bonferroni correction between multivitamin and zinc treatment P ≤ 0.05.

d

ANOVA post-hoc comparison with Bonferroni correction between multivitamin and placebo treatment P ≤ 0.05.